Reach Medical Systems Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-07-2024
- Paid Up Capital ₹ 4.00 Cr
as on 16-07-2024
- Company Age 6 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.05 Cr
as on 16-07-2024
- Revenue -20.81%
(FY 2023)
- Profit -102.70%
(FY 2023)
- Ebitda -19.39%
(FY 2023)
- Net Worth 49.59%
(FY 2023)
- Total Assets 13.30%
(FY 2023)
About Reach Medical Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹15.05 Cr.
Keerthi Maradani, Shyla Regina, Chamundeswari Maradani, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85100AP2018PTC110089
- Company No.
110089
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 2018
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Vijayawada, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Reach Medical Systems?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Keerthi Maradani  | Additional Director | 02-May-2022 | Current |
| Shyla Regina | Director | 28-Dec-2018 | Current |
| Chamundeswari Maradani | Director | 28-Dec-2018 | Current |
| Harry Xavier | Director | 28-Dec-2018 | Current |
| Ananda Maradani | Director | 28-Dec-2018 | Current |
Financial Performance of Reach Medical Systems.
Reach Medical Systems Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.81% decrease. The company also saw a substantial fall in profitability, with a 102.7% decrease in profit. The company's net worth Soared by an impressive increase of 49.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reach Medical Systems?
In 2023, Reach Medical Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Jan 2024 | ₹5.00 M | Open |
Others Creation Date: 18 Dec 2023 | ₹4.74 M | Open |
Others Creation Date: 06 Nov 2023 | ₹5.00 M | Open |
How Many Employees Work at Reach Medical Systems?
Unlock and access historical data on people associated with Reach Medical Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reach Medical Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reach Medical Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
